Vilin Bio Med Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 02, 2026. Further, the company has informed the Exchange regarding voting results.
Vilin Bio Med received a 'No Objection' from NSE for its merger with Chemgenix Laboratories. This is a crucial milestone for the amalgamation, signaling progress on a significant business development, with other approvals pending.
